Search tool

The EMCDDA has been invited to participate in the '2nd international EGM on fentanyl-related substances and emerging dangerous synthetic opioids with no known legitimate uses' organised by the International Narcotics Control Board...

The extended Scientific Committee of the EMCDDA met on 7–8 November 2017 to examine the risk assessment by the EMCDDA on AB-CHMINACA, ADB-CHIMNACA, 5F-MDMB-PINACA, CUMYL-4CN-BINACA, 4-fluoroisobutyrylfentanyl, tetrahydrofuranylfentanyl, and carfentanil.

The extended Scientific Committee of the EMCDDA met on 23 May 2017 to examine the risk assessment by the EMCDDA on furanylfentanyl.

The extended Scientific Committee of the EMCDDA met on 22 February 2017 to examine the risk assessment by the EMCDDA on N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl).